Literature DB >> 17213881

Mitochondrial oxidative function and type 2 diabetes.

Rasmus Rabøl1, Robert Boushel, Flemming Dela.   

Abstract

The cause of insulin resistance and type 2 diabetes is unknown. The major part of insulin-mediated glucose disposal takes place in the skeletal muscle, and increased amounts of intramyocellular lipid has been associated with insulin resistance and linked to decreased activity of mitochondrial oxidative phosphorylation. This review will cover the present knowledge and literature on the topics of the activity of oxidative enzymes and the electron transport chain (ETC) in skeletal muscle of patients with type 2 diabetes. Different methods of studying mitochondrial function are described, including biochemical measurements of oxidative enzyme and electron transport activity, isolation of mitochondria for measurements of respiration, and ATP production and indirect measurements of ATP production using nuclear magnetic resonance (NMR) - spectroscopy. Biochemical markers of mitochondrial content are also discussed. Several studies show reduced activity of oxidative enzymes in skeletal muscle of type 2 diabetics. The reductions are independent of muscle fiber type, and are accompanied by visual evidence of damaged mitochondria. In most studies, the reduced oxidative enzyme activity is explained by decreases in mitochondrial content; thus, evidence of a functional impairment in mitochondria in type 2 diabetes is not convincing. These impairments in oxidative function and mitochondrial morphology could reflect the sedentary lifestyle of the diabetic subjects, and the influence of physical activity on oxidative activity and mitochondrial function is discussed. The studies on insulin-resistant offspring of type 2 diabetic parents have provided important insights in the earliest metabolic defects in type 2 diabetes. These defects include reductions in basal ATP production and an attenuated response to insulin stimulation. The decreased basal ATP production does not affect overall lipid or glucose oxidation, and no studies linking changes in oxidative activity and insulin sensitivity in type 2 diabetes have been published. It is concluded that evidence of a functional impairment in mitochondria in type 2 diabetes is not convincing, and that intervention studies describing the correlation between changes in insulin resistance and mitochondrial function in type 2 diabetes are lacking. Specific effects of regular physical training and muscular work on mitochondrial function and plasticity in type 2 diabetes remain an important area of research.

Entities:  

Mesh:

Year:  2006        PMID: 17213881     DOI: 10.1139/h06-071

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  39 in total

1.  Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus.

Authors:  Neda Rajamand Ekberg; Kerstin Brismar; Jonas Malmstedt; Mari-Anne Hedblad; Ulf Adamson; Urban Ungerstedt; Natalie Wisniewski
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Naringin Improves Neuronal Insulin Signaling, Brain Mitochondrial Function, and Cognitive Function in High-Fat Diet-Induced Obese Mice.

Authors:  Dongmei Wang; Junqiang Yan; Jing Chen; Wenlan Wu; Xiaoying Zhu; Yong Wang
Journal:  Cell Mol Neurobiol       Date:  2015-05-05       Impact factor: 5.046

Review 3.  Mitochondrial medicine for aging and neurodegenerative diseases.

Authors:  P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2008-06-20       Impact factor: 3.843

Review 4.  The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.

Authors:  Ines Pagel-Langenickel; Jianjun Bao; Liyan Pang; Michael N Sack
Journal:  Endocr Rev       Date:  2009-10-27       Impact factor: 19.871

Review 5.  Mitochondrial fitness and insulin sensitivity in humans.

Authors:  J Szendroedi; M Roden
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

6.  Independent effect of type 2 diabetes beyond characteristic comorbidities and medications on immediate but not continued knee extensor exercise hyperemia.

Authors:  Veronica J Poitras; Robert F Bentley; Diana H Hopkins-Rosseel; Stephen A LaHaye; Michael E Tschakovsky
Journal:  J Appl Physiol (1985)       Date:  2015-06-05

7.  Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart.

Authors:  Tara L Croston; Dharendra Thapa; Anthony A Holden; Kevin J Tveter; Sara E Lewis; Danielle L Shepherd; Cody E Nichols; Dustin M Long; I Mark Olfert; Rajaganapathi Jagannathan; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

Review 8.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

Review 9.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

10.  Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.

Authors:  Tingqing Guo; William Jou; Tatyana Chanturiya; Jennifer Portas; Oksana Gavrilova; Alexandra C McPherron
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.